Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paul Klenerman and John Frater.
Paul Klenerman
Connection Strength
0.472
John Frater
  1. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021 08; 8(8):e474-e485.
    View in: PubMed
    Score: 0.238
  2. Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. Nat Commun. 2021 08 17; 12(1):5061.
    View in: PubMed
    Score: 0.060
  3. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021 04 06; 12(1):2055.
    View in: PubMed
    Score: 0.059
  4. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. Nat Commun. 2021 03 29; 12(1):1951.
    View in: PubMed
    Score: 0.059
  5. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol. 2020 11; 21(11):1336-1345.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.